U.S. Markets open in 13 hrs, 38 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,430.21 | 12.78 | 0.11% |
| NASDAQ | 2,380.38 | -8.70 | -0.36% |
| S&P 500 | 1,277.72 | 3.18 | 0.25% |
| Day Low 09:31 AM EDT | 2.30 | |
|---|---|---|
| Day High 10:47 AM EDT | 2.42 |
|
| Range | 0.12 | |
| Volume | 19,442 | |
| 30-Day Avg. Vol. | 54,000 |
|
| Difference | -64.00% | |
| Market Cap. | 177.67 M | |
| Change | -2.27 M | |
| Shares Out. | 75.88 M | |
| Percent Traded | 0.03% | |
| Revenue | 0 | |
| Earnings | -22.48 M | |
| EPS (TTM) | -0.26 |
| 52-Wk Low 8/5/08 | 2.10 | |
|---|---|---|
| 52-Wk High 8/22/07 | 48.40 |
|
| Range | 46.30 | |
| Prev. Close 8/20/08 | 2.37 | |
| Today's Open | 2.37 | |
| Change | 0.00% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 0.2401 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | — |
What do you get when you cross a petunia with a person? Protalix Biotherapeutics hopes that whatever it is, it cures or prevents diseases. The biotech firm is splicing human DNA into plant cells and growing ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | — 3/31/08 | -0.07 3/31/08 |
—
—
|
| Last Quarter | — 6/30/08 | -0.06 6/30/08 |
—
—
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | -320,000.00 | -692,000.00 |
| Operating Income | -4.90 M | -24.50 M |
| Net Income | -4.23 M | -22.48 M |
Real-Time Quote
